RFK Jr. has gained a following for his questioning of vaccines. He has vowed to take on the food and drug industries and focus on chronic health conditions.

Labcorp Holdings Inc. leverages strategic moves like the Fortrea spin-off and Invitae acquisition to drive growth. Read more ...

Research and Development (R&D) Expenses: R&D expenses were $82.8 million for the fourth quarter of 2024, compared to $77.5 million for the fourth quarter of 2023, and $301.3 million for the full year ...

Among the industry’s top priorities for the appointees are ensuring regulatory decisions are science- and risk-based, supply ...

Indian Prime Minister Narendra Modi has heaped praise on Trump in hopes of avoiding the tariffs that the White House has slapped on other countries.

Positive IHL-42X PK findings for the treatment of Obstructive Sleep Apnea (OSA) support future 505(b)(2) New Drug Application (NDA) submissionNew OSA Clinical Advisory Board Announced; Appoints Dr. Al ...

Trial Met the Primary Endpoint and Provides Evidence of GTx-104 Clinical Benefit Compared to Orally Administered Nimodipine. New Drug Application (NDA) Submission Expected in the ...

But like the normal seasonal flu, bird flu changes over time, so the vaccine would need to be updated with the current strain before ... treated with an antiviral drug for flu, the CDC said.

The Senate has approved Trump’s most controversial picks, including Tulsi Gabbard and RFK Jr. Here’s the full list and ...

In confirmation hearings for his nomination as secretary of the Department of Health and Human Services, the focus was on domestic issues. The agency has a vast global scope as well.

This disruption to Germany’s position as the leader in pharmaceuticals in the ... with a new amendment to US Food and Drug Administration (FDA) rules demanding proof of efficacy and accurate ...

The notion that we’re trapped in Stone Age bodies in a fast-food world is driving the current craze for Paleolithic ... says the Tsimane study co-leader Leonard. Studies suggest that indigenous ...